Categories: CancerDiagnosticsNews

Nabsys Announces Eight Electronic Genome Mapping Presentations at American Society of Human Genetics (ASHG) 2025 Annual Meeting

Nabsys to host a CoLab Session in partnership with Hitachi High-Tech America, Inc. and Boston Children’s Hospital

PROVIDENCE, R.I., Sept. 30, 2025 /PRNewswire/ — Nabsys 2.0, LLC (Nabsys), a pioneer in electronic genome mapping technology, announces the presentation of eight presentations at the American Society of Human Genetics (ASHG) Annual Meeting taking place on October 14-18, 2025, in Boston, MA. In addition to seven posters, the Company will host a Google Colaboratory (Colab) Session in partnership with Hitachi High-Tech America, Inc. and Boston Children’s Hospital.

Details of the posters and CoLab session are as follows:

CoLab Session: Electronic Genome Mapping as Part of a Comprehensive Multi-Omics Strategy for Undiagnosed Disorders
Presenter: Catherine Brownstein, M.P.H., Ph.D., Boston Children’s Hospital
Location: Theater 1, Exhibit & Poster Hall/Lower Level
Date/Time: Wednesday, October 15, 2025 | 12:00 PM – 12:30 PM EDT

Title: Accelerated Electronic Genome Mapping with Simultaneous Dual Nicking & Labeling: Boosting Structural Variant Calling on the OhmX Platform
Presenter: Jay Sage, Ph.D., Nabsys
Poster #: 4089W
Session: Omics Technologies Poster Wednesday Session
Date/Time: Wednesday, October 15, 2025 | 2:30 PM – 4:30 PM EDT

Title:
 Electronic Genome Mapping as a Tool for Detection of TP53 Deletions in Genomic Analysis

Presenter: Yang Zhang, Ph.D., Nabsys
Poster #: 8028T
Session: Molecular and Cytogenetic Diagnostics Poster Thursday Session
Date/Time: Thursday, October 16, 2025 | 2:30 PM – 4:30 PM EDT

Title: Electronic Genome Mapping for High-Throughput Analysis of Repeat Expansion Disorders
Presenter: Syndi Koltz, Ph.D., Nabsys
Poster #: 4065T
Session: Omics Technologies Poster Thursday Session
Date/Time: Thursday, October 16, 2025 | 2:30 PM – 4:30 PM EDT

Title: Improving Electronic Genome Mapping Coverage With CRISPR/Cas9
Presenter: Lindsay Schneider, Ph.D., Nabsys
Poster #: 4068T
Session: Omics Technologies Poster Thursday Session
Date/Time: Thursday, October 16, 2025 | 2:30 PM – 4:30 PM EDT

Title: Comprehensive Multi-Omics Study of Interstitial Cystitis/Bladder Pain Syndrome
Presenter: Elicia A. Estrella, M.S., LCGC, Boston Children’s Hospital
Poster #: 4101T
Session: Omics Technologies Poster Thursday Session
Date/Time: Thursday, October 16, 2025 | 2:30 PM – 4:30 PM EDT

Title: Electronic Genome Mapping of Somatic Structural Variants
Presenter: John Thompson, Ph.D., Nabsys
Poster #: 9031F
Session: Cancer Poster Friday Session
Date/Time: Friday, October 17, 2025 | 2:30 PM – 4:30 PM EDT

Title: Development of a Classification Model for Predicting Structural Polymorphism of EGM-Detected Variants in the Human Genome
Presenter: Sachiho Abe, M.S., Hitachi High-Tech America, Inc.
Poster #: 5078F
Session: Molecular Effects of Genetic Variation Poster Friday Session
Date/Time: Friday, October 17, 2025 | 2:30 PM – 4:30 PM EDT

Following the conclusion of each session, the presentation will be available on the “Resources” section of the Company’s website at www.nabsys.com/resources?category=Posters.

About Nabsys 2.0, LLC

The Nabsys 2.0, LLC (“Nabsys”) mission is to advance the understanding of disease, increase diagnostic yield, and improve patient outcomes by enabling routine, accurate, cost-effective analysis of genomic structural variation. Located in Providence, RI, Nabsys employs a growing interdisciplinary group of dedicated scientists, engineers, and other professionals committed to the advancement of genomic analysis.

For more information, visit https://www.nabsys.com.

About Hitachi High-Tech America, Inc.

Hitachi High-Tech America, Inc. (HTA) is a privately-owned global affiliate company that operates within the Hitachi Group companies. HTA sells and services semiconductor manufacturing equipment, analytical instrumentation, scientific instruments, and bio-related products, as well as industrial equipment, and electronic and industrial materials. HTA is dedicated to successful and profitable collaboration with leading companies worldwide, with a direction towards providing customers with superior quality products and services at fair and competitive prices. For more information, please visit https://www.hitachi-hightech.com/us/en.

Media Contact

David Rosen
Argot Partners
David.rosen@argotpartners.com
646-461-6387

View original content to download multimedia:https://www.prnewswire.com/news-releases/nabsys-announces-eight-electronic-genome-mapping-presentations-at-american-society-of-human-genetics-ashg-2025-annual-meeting-302570230.html

SOURCE Nabsys

Staff

Recent Posts

BioSonic Bloom: What Published Research Says About 528 Hz and 432 Hz Audio Frequency Programs

An In-Depth Analysis of Digital Sound Frequency Programs, Binaural Beats Research, and Key Considerations for…

18 hours ago

Best TRT Injection for 2026: Fridays Lists Prescription Testosterone in Injectable and Oral Formats as Men Compare Telehealth Hormone Options

Independent analysis examines Fridays' published TRT program structure, delivery format options, and what clinical research…

18 hours ago

How Does Ozempic Work For Weight Loss? Best Weight Loss Supplement Launch By PhenQ

Ozempic for Weight Loss: Does It Work and Is It Safe? Read PhenQ Details –…

18 hours ago

Best NAD+ Injection for 2026: Sprout Health Lists Compounded NAD+ at $149 First Month as Telehealth Longevity Programs Expand

Prescription NAD+ Injection Access, At-Home Administration Models, Compounding Standards, and What Consumers Should Know Before…

18 hours ago

Is SynergyRx GLP-1 Legitimate? Platform Lists Compounded Semaglutide at $200 With Oral Tablet Options

Telehealth Provider Offers FDA-Approved and Compounded Weight Loss Medications in All 50 States, Subject to…

2 days ago